Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19

Myopericarditis has been identified as a potential adverse event of several vaccines in the medical literature. Here we present a case of a 30-year-old male who had myopericarditis a week after receiving the second booster dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Elhouderi, Eiman, Elsawalhy, Eman, Kabbani, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224764/
https://www.ncbi.nlm.nih.gov/pubmed/35755512
http://dx.doi.org/10.7759/cureus.25264
Descripción
Sumario:Myopericarditis has been identified as a potential adverse event of several vaccines in the medical literature. Here we present a case of a 30-year-old male who had myopericarditis a week after receiving the second booster dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. The patient's clinical course was not severe and had a full recovery after a week of treatment.

Ejemplares similares